Showing results (331-340 of 450) with videos related to
Sort By:
Pageof 45
American Journal of Physiology. Renal Physiology|August 22, 2014
Decreasing podocyte number during human kidney intrauterine developmentA Crobe, M Desogus, A Sanna, et al.International Journal of Clinical Pharmacology Research|January 1, 1987
Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseasesF Fraschini, P C Braga, R Cosentina, et al.Minerva Medica|March 1, 1988
[Arterial hypertension with hypokalemia]G Montanari, F Zanaletti, G C Quadrelli, et al.Oncology|January 1, 1990
Elliptinium acetate in metastatic breast cancer--a phase II studyA U Buzdar, G N Hortobagyi, L T Esparza, et al.Journal of Hypertension|August 31, 1999
Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjectsM Failla, A Grappiolo, G Emanuelli, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancerK Hoffman, F A Holmes, G Fraschini, et al.Journal of Pineal Research|December 25, 2004
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's diseaseEgemen Savaskan, Mohammed A Ayoub, Rivka Ravid, et al.European Journal of Histochemistry : EJH|January 11, 2007
Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's diseaseP Brunner, N Sözer-Topcular, R Jockers, et al.Biomed Research International|December 22, 2016
Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral FractureSimona Bolamperti, Isabella Villa, Alice Spinello, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancerK Dhingra, D Frye, R A Newman, et al.Pageof 45